Digital Redefining pharmaceutical case processing in the age of AI a... Pharmaceutical case processing is witnessing a 15% annual increase in adverse event reports, according to
R&D Transforming clinical data management systems for biotechnol... In the dynamic environment of biotechnology trials, the significance of Clinical Data Management systems (CDMs) cannot be overstated.
Digital The future of pharmacovigilance – beginning the shift to AI-... In 2023, the pharmaceutical industry saw a surge in innovation.
Digital Generative AI and its impact on speed to market for pharmace... Generative AI (GenAI) is revolutionising the life sciences, and we’re just scratching the surface.
Digital Digitisation of drug R&D: Avoiding new for novelty’s sake AI and wearable medical devices are already advancing patient care, and transformative use of data and digital innovation is set to enable a new generation of medicines, faster.
R&D How to optimise commercial-scale ATMP manufacturing through ... This is the second part of our series, "The ATMP Manufacturer's Guide to Commercialisation and cGMP Compliance".
Oncology Liver cancer diagnostic gets FDA breakthrough status, with P... Mursla Bio CEO and founder Pierre Arséne discusses the breakthrough designation from the FDA for their blood test to catch liver cancer early.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
